![Shankar Swaminathan](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Shankar-Swaminathan-Associate-Director-Drug-Product-Development-Astellas-Institute-for-Regenerative-Medicine.webp.png/fit-in/500x500/filters:no_upscale())
![](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Astellas-Pharma.jpg)
Shankar Swaminathan
Associate Director Drug Product Development,
Astellas Institute for Regenerative Medicine
Shankar is the Team Lead for Drug Product Development at Astellas Institute of Regenerative Medicine. He has a doctoral degree in pharmaceutics and over 15 years of experience in industry and academia. He has overseen product development from early-stage discovery through late-stage submissions and validation. Shankar is an expert in aseptic drug product development, quality-by-design, advanced drug delivery, cryopreservation technology, CTM campaign execution and management, fill-finish, modified release solid orals, and ocular drug delivery. He has published 15+ peer-reviewed publications, commentaries, and blogs, and serves as an editorial board member in Scientific Reports and a reviewer for over 20 peer-reviewed journals.
Sessions
-
25-Jun-2024Salon BManufacturing and scale up challenges in Allogeneic Cell Therapy Development